SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-08-010786
Filing Date
2008-05-01
Accepted
2008-05-01 14:15:06
Documents
1
Period of Report
2008-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4074
  Complete submission text file 0001140361-08-010786.txt   6082
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 1101 FIFTH AVENUE SUITE 370 SAN RAFAEL CA 94901
Business Address 1101 FIFTH AVENUE SUITE 370 SAN RAFAEL CA 94901 4154481200
EASTBOURNE CAPITAL MANAGEMENT LLC/CA (Reporting) CIK: 0001140888 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 08793904